Leveraging various extracellular matrix levels to assess prognosis and sensitivity to immunotherapy in patients with ovarian cancer

BACKGROUND: Ovarian cancer (OC) is the fifth leading cause of cancer-related deaths among women. Late diagnosis and heterogeneous treatment result in a poor prognosis for patients with OC. Therefore, we aimed to develop new biomarkers to predict accurate prognoses and provide references for individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Youqun, Lei, Xingxing, Sun, Lisha, Liu, Yu, Yang, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203472/
https://www.ncbi.nlm.nih.gov/pubmed/37228494
http://dx.doi.org/10.3389/fonc.2023.1163695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203472/
https://www.ncbi.nlm.nih.gov/pubmed/37228494
http://dx.doi.org/10.3389/fonc.2023.1163695

Ejemplares similares